HK1125315A1 - Recombinant attenuated clostridium organisms and vaccine - Google Patents

Recombinant attenuated clostridium organisms and vaccine

Info

Publication number
HK1125315A1
HK1125315A1 HK09104268.8A HK09104268A HK1125315A1 HK 1125315 A1 HK1125315 A1 HK 1125315A1 HK 09104268 A HK09104268 A HK 09104268A HK 1125315 A1 HK1125315 A1 HK 1125315A1
Authority
HK
Hong Kong
Prior art keywords
vaccine
recombinant attenuated
attenuated clostridium
clostridium organisms
organisms
Prior art date
Application number
HK09104268.8A
Other languages
English (en)
Inventor
Mark D Cochran
Gary Petersen
Steven V Lair
Richard Synenki
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of HK1125315A1 publication Critical patent/HK1125315A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Feed For Specific Animals (AREA)
HK09104268.8A 2006-04-17 2009-05-08 Recombinant attenuated clostridium organisms and vaccine HK1125315A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79255306P 2006-04-17 2006-04-17
PCT/US2007/009135 WO2007123850A2 (en) 2006-04-17 2007-04-12 Recombinant attenuated clostridium organisms and vaccine

Publications (1)

Publication Number Publication Date
HK1125315A1 true HK1125315A1 (en) 2009-08-07

Family

ID=38625523

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09104268.8A HK1125315A1 (en) 2006-04-17 2009-05-08 Recombinant attenuated clostridium organisms and vaccine

Country Status (24)

Country Link
US (3) US7732187B2 (pt)
EP (2) EP2368571A1 (pt)
JP (2) JP5551933B2 (pt)
KR (1) KR20080110908A (pt)
CN (1) CN101489584B (pt)
AR (2) AR060471A1 (pt)
AU (1) AU2007240949B2 (pt)
BR (1) BRPI0711572A2 (pt)
CA (1) CA2649426C (pt)
CO (1) CO6140037A2 (pt)
EC (1) ECSP088827A (pt)
ES (1) ES2401810T3 (pt)
HK (1) HK1125315A1 (pt)
IL (1) IL194714A (pt)
MX (1) MX2008013451A (pt)
NO (1) NO20084810L (pt)
NZ (1) NZ571970A (pt)
PE (1) PE20080167A1 (pt)
PL (1) PL2007420T3 (pt)
RU (2) RU2593945C2 (pt)
TW (1) TWI338045B (pt)
UA (2) UA109105C2 (pt)
WO (1) WO2007123850A2 (pt)
ZA (1) ZA200808872B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060083750A1 (en) * 1999-11-19 2006-04-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis
US20070077256A1 (en) 1999-11-19 2007-04-05 Los Angeles Biomedical Research Institute Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
WO2009134891A2 (en) * 2008-04-29 2009-11-05 Immunexcite, Inc. Immunomodulating compositions and methods of use thereof
WO2012033814A2 (en) * 2010-09-10 2012-03-15 Viropharma Incorporated Environmental clostridial bacteriotherapy and related formulations and methods of manufacture and use
EA035513B1 (ru) 2011-07-22 2020-06-29 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" ВАКЦИНА, СОДЕРЖАЩАЯ БЕЛОК Als3, ДЛЯ ЛЕЧЕНИЯ У МЛЕКОПИТАЮЩЕГО АБСЦЕССА КОЖИ, ОБУСЛОВЛЕННОГО STAPHYLOCOCCUS AUREUS
TWI592422B (zh) * 2012-03-02 2017-07-21 再生元醫藥公司 抗艱難梭狀芽孢桿菌毒素之人類抗體
EP2911688B1 (en) 2012-10-26 2019-10-16 Intervet International B.V. Cross-protecting salmonella vaccines
EA030005B1 (ru) 2013-03-15 2018-06-29 Лос-Анджелес Биомедикал Ресерч Институт Эт Харбор-Укла Медикал Центер Композиции и способы лечения грибковых и бактериальных патогенов
US10857216B2 (en) 2016-03-09 2020-12-08 Novadigm Therapeutics, Inc. Methods and kits for use in preventing and treating vulvovaginal candidiasis
CN109602898B (zh) * 2018-12-28 2022-02-22 江苏省农业科学院 一种产气荚膜梭菌α毒素基因工程疫苗及其制备方法
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN114621963A (zh) * 2022-03-11 2022-06-14 牧原食品股份有限公司 一种猪魏氏梭菌a型的亚单位疫苗及其制备

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1483042A (en) 1974-07-29 1977-08-17 Lapointe J Anti-tumour product of bacterial origin
SU627612A1 (ru) 1977-09-30 1980-02-05 Zemlyakova V P Препарат земл ковой в.п. против клюстридиозов животных и птиц
GB9115332D0 (en) * 1991-07-16 1991-08-28 Connaught Lab Manipulation of gene copy number in bordetella
NZ253189A (en) 1992-05-20 1996-08-27 Secr Defence Peptides comprising amino acid sequences of clostridium perfringens alpha toxins, vaccines containing them, antibodies and their use
GB9605222D0 (en) 1996-03-12 1996-05-15 Secr Defence Clostridium perfringens epsilon toxin vaccines
PT892054E (pt) * 1997-06-20 2007-02-28 Intervet Int Bv Vacina de clostridium perfringens
RU2129441C1 (ru) * 1997-12-10 1999-04-27 Пирожков Михаил Константинович Вакцина, ассоциированная против анаэробной энтеротоксемии и эшерихиоза поросят
US6399074B1 (en) * 1998-07-24 2002-06-04 Megan Health, Inc. Live attenuated salmonella vaccines to control avian pathogens
AUPQ899700A0 (en) * 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US6908620B2 (en) * 2002-12-09 2005-06-21 University Of Georgia Research Foundation, Inc. Coccidial vaccine and methods of making and using same
CN102861325A (zh) * 2003-11-10 2013-01-09 Uab研究基金会 减少细菌携带和中枢神经系统侵害的组合物及其使用方法
MY149604A (en) 2005-04-18 2013-09-13 Schering Plough Ltd C.perfringens alpha toxoid vaccine

Also Published As

Publication number Publication date
BRPI0711572A2 (pt) 2011-11-16
EP2007420B1 (en) 2013-03-06
CA2649426C (en) 2014-04-01
ES2401810T3 (es) 2013-04-24
PL2007420T3 (pl) 2013-08-30
CN101489584A (zh) 2009-07-22
CA2649426A1 (en) 2007-11-01
US20110008389A1 (en) 2011-01-13
US20070286874A1 (en) 2007-12-13
AR060471A1 (es) 2008-06-18
CO6140037A2 (es) 2010-03-19
ECSP088827A (es) 2008-11-27
JP5551933B2 (ja) 2014-07-16
TWI338045B (en) 2011-03-01
CN101489584B (zh) 2013-05-01
ZA200808872B (en) 2009-11-25
NZ571970A (en) 2012-02-24
WO2007123850A3 (en) 2008-03-06
AR079941A2 (es) 2012-02-29
TW200801182A (en) 2008-01-01
IL194714A0 (en) 2011-08-01
AU2007240949B2 (en) 2013-03-14
AU2007240949A1 (en) 2007-11-01
US7807456B2 (en) 2010-10-05
RU2011147308A (ru) 2013-05-27
JP2009533071A (ja) 2009-09-17
MX2008013451A (es) 2008-10-30
RU2593945C2 (ru) 2016-08-10
NO20084810L (no) 2009-01-16
IL194714A (en) 2015-03-31
EP2007420A2 (en) 2008-12-31
US7972604B2 (en) 2011-07-05
RU2008144913A (ru) 2010-05-27
KR20080110908A (ko) 2008-12-19
US7732187B2 (en) 2010-06-08
RU2445364C2 (ru) 2012-03-20
UA109105C2 (uk) 2015-07-27
PE20080167A1 (es) 2008-03-10
JP2013255518A (ja) 2013-12-26
UA95951C2 (en) 2011-09-26
US20100166800A1 (en) 2010-07-01
EP2368571A1 (en) 2011-09-28
WO2007123850A2 (en) 2007-11-01

Similar Documents

Publication Publication Date Title
IL194714A0 (en) Recombinant attenuated clostridium organisms and vaccine
HK1218427A1 (zh) 改進的疫苗及其使用方法
GB2451014B (en) Engineered Listeria comprising a modified ActA-antigen fusion protein and its use as a vaccine
IL216712A (en) Polypeptides derived from 1depdc
GB0607088D0 (en) Vaccine
EP1976864A4 (en) NEW PEPTIDE AND ITS USE
ZA200904061B (en) Fuel composition and its use
EP2318429A4 (en) PROMININ-1 PEPTIDE FRAGMENTS AND ITS USE
IL196861A0 (en) Antibodies against ccr5 and uses thereof
GB0615635D0 (en) Immunogenic proteins and uses thereof
IL195525A0 (en) Replikin peptides and uses thereof
GB0604187D0 (en) Peptide and uses thereof
EP2049661A4 (en) RECOMBINANT BUTYRYLCHOLINESTERASE WITH LONG HALF-LIFE
IL180839A0 (en) Vaccine comprising recombinant ct or lt toxin
IL213318A0 (en) C1orf59 peptides and vaccines including the same
IL214453A0 (en) Vangli peptides and vaccines including the same
GB0818065D0 (en) Immunogenic peptides and uses thereof
GB0614460D0 (en) Vaccines
IL220146A0 (en) Tmem22 peptides and vaccines including the same
EP1985695A4 (en) RECOMBINANT MICROORGANISM
SI2032708T1 (sl) Rekombinantni novirabdovirusi in njihove uporabe
EP2196477A4 (en) MODIFIED RECOMBINANT HUMAN ENDOSTATIN AND ITS APPLICATION
IL192800A0 (en) Fgf2-binding peptides and uses thereof
EP2195338A4 (en) N-TERMINAL MODIFIED INTERFERON ALPHA
PL378824A1 (pl) Peptyd i jego zastosowanie

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170412